Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Sector: Healthcare

Overview Zen Rating Price Value Growth Financials

Momentum Sentiment Forecast Dividends Due Diligence

Ticker	Company	Market Cap	ROE	ROA	ROCE	ROIC	D/E	Current Ratio	Gross Margin	Profit Margin	Operating Margin
AGIO	AGIOS PHARMACEUTICALS INC	$2.22B	-34.10%	-31.70%	-37.62%	-35.00%	0.07	14.19	90.00%	-639.80%	-641.38%
LXEO	LEXEO THERAPEUTICS INC	$361.20M	-47.50%	-41.70%	-37.01%	-61.60%	0.08	14.16	N/A	N/A	N/A
PBM	PSYENCE BIOMEDICAL LTD	$7.02M	-58.60%	-55.80%	-40.88%	-138.50%	0.04	14.62	N/A	N/A	N/A
ALDX	ALDEYRA THERAPEUTICS INC	$137.53M	-57.30%	-36.30%	-60.44%	-576.70%	0.58	2.72	N/A	N/A	N/A
SLGL	SOL-GEL TECHNOLOGIES LTD	$242.30M	-3.20%	-2.60%	-2.00%	-4.00%	0.14	8.84	100.00%	-5.70%	-5.70%
RNA	ATRIUM THERAPEUTICS INC	$222.54M	N/A	N/A	N/A	N/A	0.25	13.04	N/A	N/A	N/A
ALMR	ALAMAR BIOSCIENCES INC	$1.78B	N/A	N/A	N/A	N/A	-0.73	5.88	N/A	N/A	N/A
NVCR	NOVOCURE LTD	$2.01B	-50.80%	-16.50%	-32.15%	-20.90%	1.38	2.90	75.20%	-25.70%	-27.19%
ENLV	ENLIVEX LTD	$121.54M	248.10%	206.40%	69.81%	279.90%	0.20	193.24	N/A	N/A	N/A
LONA	LEONABIO INC	$81.54M	-381.00%	-225.70%	-199.33%	-1,888.60%	0.45	10.38	N/A	N/A	N/A
OPK	OPKO HEALTH INC	$1.13B	-16.80%	-11.00%	-7.32%	-15.40%	0.54	3.61	36.00%	-36.60%	-21.52%
IDYA	IDEAYA BIOSCIENCES INC	$3.46B	-14.00%	-12.80%	-14.51%	-15.80%	0.10	10.74	100.00%	-62.20%	-62.17%
PDSB	PDS BIOTECHNOLOGY CORP	$47.22M	-346.00%	-102.40%	-199.49%	-237.90%	5.34	2.26	N/A	N/A	N/A
NVAX	NOVAVAX INC	$1.54B	N/A	-7.40%	-9.20%	-9.70%	-8.21	2.48	85.00%	-14.70%	-10.81%
SOPH	SOPHIA GENETICS SA	$365.72M	-140.60%	-49.00%	-67.13%	-101.20%	2.44	2.06	67.30%	-99.70%	-91.29%
IMDX	INSIGHT MOLECULAR DIAGNOSTICS INC	$182.12M	N/A	-119.10%	-167.96%	-981.20%	-4.78	2.54	51.30%	-2,454.60%	-2,449.36%
CVRX	CVRX INC	$149.40M	-120.80%	-48.40%	-51.81%	-68.50%	2.43	10.20	86.20%	-89.10%	-79.14%
DOMH	DOMINARI HOLDINGS INC	$66.26M	-47.50%	-35.60%	N/A	-24.50%	1.70	N/A	100.00%	-31.40%	-17.98%
MDGL	MADRIGAL PHARMACEUTICALS INC	$12.21B	-50.20%	-25.40%	-31.79%	-29.40%	1.26	3.50	93.10%	-27.30%	-24.95%
IXHL	INCANNEX HEALTHCARE INC	$47.74M	-81.00%	-76.10%	-61.79%	-1,739.50%	0.07	41.57	N/A	N/A	N/A
LYEL	LYELL IMMUNOPHARMA INC	$327.61M	-85.70%	-66.40%	-78.55%	-87.90%	0.28	7.24	100.00%	-849,675.90%	-849,675.86%
GALT	GALECTIN THERAPEUTICS INC	$304.92M	N/A	-165.90%	-220.99%	-21.00%	-1.11	2.15	N/A	N/A	N/A
ALGS	ALIGOS THERAPEUTICS INC	$36.20M	-139.50%	-90.90%	-226.95%	-167.20%	1.03	2.56	100.00%	-1,919.70%	-1,989.08%
AGMB	AGOMAB THERAPEUTICS NV	$658.92M	-39.20%	-34.70%	-46.19%	-629.60%	0.17	6.52	N/A	N/A	N/A
MOBI	MOBIA MEDICAL INC	$440.55M	N/A	N/A	N/A	N/A	-0.37	6.06	N/A	N/A	N/A
BIO	BIO-RAD LABORATORIES INC	$7.90B	2.40%	1.70%	3.06%	2.90%	0.43	3.21	51.90%	6.50%	10.49%
ACXP	ACURX PHARMACEUTICALS INC	$6.79M	-153.90%	-101.70%	-106.92%	322.60%	0.36	3.78	N/A	N/A	N/A
AVLN	AVALYN PHARMA INC	$1.23B	N/A	N/A	N/A	N/A	-0.11	11.03	N/A	N/A	N/A
GRDX	GRIDAI TECHNOLOGIES CORP	$29.61M	-63.50%	-11.00%	-26.43%	-39.90%	1.10	0.16	-1,707.20%	-11,664.80%	-11,263.67%
CLYM	CLIMB BIO INC	$759.85M	-31.50%	-30.40%	-35.60%	-36.30%	0.03	27.86	N/A	N/A	N/A
CGEN	COMPUGEN LTD	$223.15M	47.70%	27.50%	28.17%	173.00%	0.53	6.23	88.10%	48.00%	48.01%
INKT	MINK THERAPEUTICS INC	$57.59M	N/A	-118.60%	-403.62%	182.80%	-1.82	1.38	N/A	N/A	N/A
CNXU	CONEXEU SCIENCES INC	$288.99M	N/A	N/A	N/A	N/A	0.14	7.89	N/A	N/A	N/A
ATRA	ATARA BIOTHERAPEUTICS INC	$98.03M	N/A	-35.30%	-40.63%	-10.20%	-1.54	2.16	96.10%	-40.90%	-25.20%
FATE	FATE THERAPEUTICS INC	$348.51M	-58.90%	-39.40%	-51.10%	-39.90%	0.59	5.85	100.00%	-2,056.80%	-2,056.79%
QDEL	QUIDELORTHO CORP	$1.23B	-56.30%	-20.70%	-21.21%	-20.60%	2.04	1.43	45.00%	-45.60%	-37.25%
MANE	VERADERMICS INC	$5.10B	N/A	N/A	N/A	N/A	0.02	59.12	N/A	N/A	N/A
ATR	APTARGROUP INC	$8.04B	14.40%	7.60%	13.32%	19.70%	0.93	1.66	36.70%	10.00%	13.88%
ACIU	AC IMMUNE SA	$255.37M	-124.00%	-40.50%	-146.14%	1,976.70%	3.36	0.87	100.00%	-1,788.80%	-1,783.31%
CLRB	CELLECTAR BIOSCIENCES INC	$22.14M	-321.20%	-153.20%	-333.67%	1,004.80%	1.92	1.90	N/A	N/A	N/A
XFOR	X4 PHARMACEUTICALS INC	$380.11M	-94.90%	-48.10%	-36.88%	-92.30%	0.61	10.18	81.80%	-1,106.30%	-1,008.50%
PLSE	PULSE BIOSCIENCES INC	$2.01B	-86.70%	-73.60%	-103.82%	-847.60%	0.23	7.26	-21.00%	-9,929.00%	-9,929.03%
SGMT	SAGIMET BIOSCIENCES INC	$473.57M	-37.60%	-35.50%	-42.47%	-54.90%	0.05	20.34	N/A	N/A	N/A
CGEM	CULLINAN THERAPEUTICS INC	$1.09B	-51.80%	-47.90%	-60.09%	-63.60%	0.10	10.28	N/A	N/A	N/A
RLAY	RELAY THERAPEUTICS INC	$3.62B	-43.90%	-40.10%	-40.71%	-48.90%	0.09	22.13	100.00%	-2,554.10%	-2,554.14%
FEMY	FEMASYS INC	$12.32M	-258.10%	-73.70%	-80.87%	-103.20%	1.26	3.91	61.60%	-521.80%	-453.89%
NNVC	NANOVIRICIDES INC	$32.47M	-92.70%	-81.60%	-88.39%	-143.20%	0.12	3.17	N/A	N/A	N/A
RDNT	RADNET INC	$5.42B	-1.40%	-0.40%	2.04%	2.10%	2.34	1.17	11.30%	-0.70%	3.09%
RDY	DR REDDYS LABORATORIES LTD	$11.99B	12.10%	8.00%	14.31%	18.40%	0.53	1.80	52.80%	12.80%	17.54%
RNTX	REIN THERAPEUTICS INC	$88.11M	-163.70%	-124.30%	-402.50%	976.80%	1.27	0.40	N/A	N/A	N/A
COAG	HEMAB THERAPEUTICS HOLDINGS INC	$1.40B	N/A	N/A	N/A	N/A	-0.07	12.85	N/A	N/A	N/A
CGTX	COGNITION THERAPEUTICS INC	$95.76M	-72.70%	-53.10%	-65.02%	811.40%	0.21	5.92	N/A	N/A	N/A
PBLS	PARABILIS MEDICINES INC	N/A	N/A	N/A	N/A	N/A	-0.25	6.12	N/A	N/A	N/A
RLMD	RELMADA THERAPEUTICS INC	$663.96M	-71.20%	-64.50%	-26.47%	-73.70%	0.08	18.26	N/A	N/A	N/A
DSGN	DESIGN THERAPEUTICS INC	$927.49M	-33.10%	-31.30%	-31.65%	-35.40%	0.06	22.28	N/A	N/A	N/A
PRE	PRENETICS GLOBAL LTD	$297.03M	-33.20%	-26.00%	-33.61%	-36.90%	0.45	5.15	59.90%	-46.80%	-46.67%
USPH	U S PHYSICAL THERAPY INC	$1.12B	7.10%	2.90%	5.61%	12.50%	0.98	1.19	19.00%	4.40%	7.93%
CARL	CARLSMED INC	$334.10M	-60.70%	-29.80%	-28.63%	-80.80%	0.29	11.88	75.90%	-57.80%	-55.31%
KURA	KURA ONCOLOGY INC	$980.07M	-142.00%	-43.30%	-53.18%	-58.80%	5.05	6.15	99.60%	-411.20%	-409.03%
MOH	MOLINA HEALTHCARE INC	$11.86B	4.40%	1.20%	5.25%	8.10%	3.02	1.63	8.50%	0.40%	0.96%
PLRZ	POLYRIZON LTD	$24.46M	-25.40%	-24.70%	-29.77%	-73.60%	0.02	29.03	N/A	N/A	N/A
VRAX	VIRAX BIOLABS GROUP LTD	$1.80M	-75.70%	-68.10%	-76.73%	-333.40%	0.13	9.97	61.90%	-40,439.10%	-47,188.42%
ARMP	ARMATA PHARMACEUTICALS INC	$199.71M	N/A	-356.60%	-435.96%	-110.60%	-1.22	0.64	N/A	N/A	N/A
NAUT	NAUTILUS BIOTECHNOLOGY INC	$218.58M	-35.00%	-29.20%	-33.69%	-29.30%	0.23	11.85	N/A	N/A	N/A
CAMP	CAMP4 THERAPEUTICS CORP	$222.24M	-194.70%	-95.60%	-97.15%	-12,049.00%	2.41	6.15	100.00%	-2,193.70%	-2,193.72%
TFX	TELEFLEX INC	$5.95B	-28.30%	-13.90%	-15.30%	-21.20%	1.20	2.55	53.30%	-35.90%	-32.95%
OKUR	ONKURE THERAPEUTICS INC	$185.82M	-61.00%	-56.00%	-31.86%	1,401.00%	0.08	13.78	N/A	N/A	N/A
AVR	ANTERIS TECHNOLOGIES GLOBAL CORP	$1.03B	-124.40%	-101.20%	-33.71%	4,940.10%	0.06	20.93	74.30%	-5,148.80%	-5,118.21%
ATAI	ATAIBECKLEY INC	$1.83B	-366.50%	-269.00%	-276.34%	-390.80%	0.33	10.02	100.00%	-19,019.40%	-19,007.28%
GUTS	FRACTYL HEALTH INC	$127.87M	-4,573.90%	-108.80%	-128.61%	-133.10%	3.65	4.28	N/A	N/A	N/A
IBRX	IMMUNITYBIO INC	$9.33B	N/A	-165.20%	-128.27%	-60.00%	-1.74	6.67	99.30%	-606.20%	-526.54%
PLRX	PLIANT THERAPEUTICS INC	$71.21M	-59.10%	-45.10%	-57.98%	-51.60%	0.23	16.89	N/A	N/A	N/A
AKTS	AKTIS ONCOLOGY INC	$1.42B	N/A	N/A	N/A	N/A	0.14	19.49	N/A	N/A	N/A
LFCR	LIFECORE BIOMEDICAL INC	$189.42M	N/A	N/A	N/A	N/A	-7.20	3.79	N/A	N/A	N/A
CYPH	CYPHERPUNK TECHNOLOGIES INC	$71.86M	-92.40%	-80.70%	-67.26%	-113.10%	0.04	27.28	N/A	N/A	N/A
OCGN	OCUGEN INC	$504.40M	-127,987.50%	-135.50%	-184.13%	-177.20%	8.80	1.86	100.00%	-1,605.20%	-1,492.70%
DCGO	DOCGO INC	$58.08M	-89.00%	-63.20%	-131.98%	-117.00%	0.74	1.79	30.40%	-62.20%	-57.75%
RCEL	AVITA MEDICAL INC	$159.73M	N/A	-78.90%	265.45%	-176.80%	-3.23	0.48	81.40%	-62.70%	-55.50%
PHVS	PHARVARIS NV	$2.17B	-67.10%	-60.70%	N/A	-1,487.80%	0.10	N/A	N/A	N/A	N/A
ERNA	ERNEXA THERAPEUTICS INC	$7.51M	-264.10%	-151.40%	-161.56%	1,216.90%	0.54	2.89	N/A	N/A	N/A
ALLR	ALLARITY THERAPEUTICS INC	$19.09M	-109.90%	-47.30%	-157.40%	345.60%	4.05	1.23	100.00%	-3,260.60%	-3,157.10%
TLRY	TILRAY BRANDS INC	$510.48M	-86.90%	-64.60%	-79.57%	-129.40%	0.35	2.79	27.70%	-156.70%	-168.48%
GNPX	GENPREX INC	$6.57M	-247.30%	-176.70%	-98.66%	6,750.40%	0.20	5.61	N/A	N/A	N/A
MDXG	MIMEDX GROUP INC	$606.21M	12.90%	9.70%	15.10%	39.70%	0.27	5.40	81.00%	7.90%	10.24%
TMCI	TREACE MEDICAL CONCEPTS INC	$295.82M	-69.50%	-31.40%	-37.07%	-28.20%	1.39	3.58	79.70%	-29.40%	-26.75%
KMTS	KESTRA MEDICAL TECHNOLOGIES LTD	$1.63B	-70.40%	-49.90%	-40.49%	-178.60%	0.32	7.32	48.80%	-176.90%	-162.71%
NKTR	NEKTAR THERAPEUTICS	$2.47B	-87.00%	-40.70%	-18.29%	-36.60%	0.33	10.21	100.00%	-284.20%	-232.01%
DMRA	DAMORA THERAPEUTICS INC	$1.83B	-122.00%	-114.60%	-45.93%	2,547.10%	0.05	22.49	N/A	N/A	N/A
ANNX	ANNEXON INC	$976.50M	-102.10%	-76.70%	-86.57%	-215.60%	0.29	6.35	N/A	N/A	N/A
CRBU	CARIBOU BIOSCIENCES INC	$181.50M	-100.10%	-72.00%	-103.44%	-78.30%	0.46	6.22	100.00%	-1,512.80%	-1,519.07%
AVXL	ANAVEX LIFE SCIENCES CORP	$246.51M	-38.80%	-35.00%	-31.54%	408.90%	0.05	20.87	N/A	N/A	N/A
LCTX	LINEAGE CELL THERAPEUTICS INC	$331.57M	-152.10%	-63.80%	-68.54%	-638.40%	1.06	6.89	99.30%	-434.40%	-470.17%
SMMT	SUMMIT THERAPEUTICS INC	$12.36B	-291.20%	-243.10%	-213.62%	-549.60%	0.19	7.41	N/A	N/A	N/A
PACB	PACIFIC BIOSCIENCES OF CALIFORNIA INC	$515.60M	-488.40%	-16.10%	-16.85%	-11.60%	329.67	5.65	37.50%	-80.30%	-75.50%
GOVX	GEOVAX LABS INC	$4.34M	-709.50%	-399.30%	-3,093.05%	-5,336.60%	5.04	1.06	N/A	N/A	N/A
XGN	EXAGEN INC	$106.30M	-113.50%	-34.80%	-38.18%	-35.30%	2.60	3.47	58.30%	-29.50%	-21.99%
QCLS	Q/C TECHNOLOGIES INC	$30.24M	-93.90%	-43.60%	-33.94%	-246.60%	0.71	3.72	N/A	N/A	N/A
KOD	KODIAK SCIENCES INC	$2.32B	-253.80%	-81.50%	-89.95%	-89.90%	1.73	3.54	N/A	N/A	N/A
PEPG	PEPGEN INC	$130.73M	-59.90%	-49.60%	-52.37%	-87.20%	0.17	14.98	N/A	N/A	N/A
ARWR	ARROWHEAD PHARMACEUTICALS INC	$12.19B	-55.40%	-18.10%	-9.57%	-9.10%	2.72	6.23	100.00%	-48.40%	-30.37%

Healthcare Industries

Industry	Stocks	1d %	1w %	1m %	1y %	P/E ratio	P/B Ratio	ROE	ROA	ROCE	Upside/Downside	Consensus
Biotechnology	607	-0.35%	+1.25%	+17.06%	+23.30%	18.36x	5.58x	-117.23%	-12.44%	-9.70%	+53.25%	Strong Buy
Diagnostics & Research	52	-0.02%	+3.31%	+13.74%	+24.32%	12.22x	3.90x	-7.05%	+5.99%	+11.73%	+5.79%	Strong Buy
Drug Manufacturers - General	20	-1.78%	-1.15%	+6.00%	+41.69%	41.49x	7.69x	+34.41%	+12.47%	+22.05%	+5.17%	Buy
Drug Manufacturers - Specialty & Generic	76	-0.55%	+0.67%	+5.56%	-33.67%	-5.96x	1.59x	+7.48%	+4.58%	+50.37%	+33.52%	Strong Buy
Healthcare Plans	10	-1.69%	+1.38%	+4.28%	+24.98%	29.47x	2.54x	+8.80%	+2.75%	+6.81%	-4.37%	Buy
Health Information Services	53	+0.95%	+5.82%	+18.00%	-47.94%	13.03x	3.44x	-8.71%	-0.43%	-0.74%	+17.15%	Buy
Medical Care Facilities	49	-0.40%	+5.21%	+14.56%	-22.16%	16.94x	5.47x	-49.37%	+6.58%	+14.89%	+11.00%	Buy
Medical Devices	135	+0.32%	+2.05%	+7.00%	-99.44%	20.88x	3.11x	+6.02%	+5.31%	+8.92%	+25.36%	Strong Buy
Medical Distribution	10	-0.08%	+4.19%	+6.35%	+10.62%	25.05x	156.87x	-97.12%	+3.72%	+24.95%	+17.15%	Buy
Medical Instruments & Supplies	54	+0.29%	+3.84%	+8.63%	-1.99%	45.23x	3.44x	+5.72%	+6.68%	+10.17%	+19.56%	Strong Buy

Healthcare Stocks FAQ

What are the best healthcare stocks to buy right now in Jul 2026?

According to Zen Ratings, our proprietary rating system that evaluates 115 factors proven to drive growth in stocks and assigns each stock in our system an overall letter grade as well as 7 individual Component Grades for Value, Growth, Momentum, Sentiment, Safety, Financials, and proprietary AI algorithms, the 3 best healthcare stocks to buy right now are:

1. Bioventus (NASDAQ:BVS)

Bioventus (NASDAQ:BVS) is the #1 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Bioventus (NASDAQ:BVS) is: Value: B, Growth: A, Momentum: B, Sentiment: A, Safety: B, Financials: B, and AI: C.

Bioventus (NASDAQ:BVS) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 14 out of 33 due diligence checks and has strong fundamentals. Bioventus has seen its stock return 72.73% over the past year, overperforming other healthcare stocks by 168 percentage points.

Bioventus has an average 1 year price target of $15.00, an upside of 27.33% from Bioventus's current stock price of $11.78.

Bioventus stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 3 analysts covering Bioventus, 33.33% have issued a Strong Buy rating, 66.67% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

2. Immucell (NASDAQ:ICCC)

Immucell (NASDAQ:ICCC) is the #2 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Immucell (NASDAQ:ICCC) is: Value: B, Growth: A, Momentum: B, Sentiment: C, Safety: C, Financials: B, and AI: B.

Immucell (NASDAQ:ICCC) has a Due Diligence Score of 19, which is -7 points lower than the healthcare sector average of 26. Although this number is below the industry average, our proven quant model rates ICCC as a "A".It passed 6 out of 33 due diligence checks and has weak fundamentals. Immucell has seen its stock return 53.94% over the past year, overperforming other healthcare stocks by 149 percentage points.

3. Electromed (NYSEMKT:ELMD)

Electromed (NYSEMKT:ELMD) is the #3 top healthcare stock out of 1066 with a Zen Rating of A. Stocks with a rating of A have had an average return of +28.5% per year. Learn more.

The Component Grade breakdown for Electromed (NYSEMKT:ELMD) is: Value: C, Growth: C, Momentum: B, Sentiment: A, Safety: B, Financials: A, and AI: C.

Electromed (NYSEMKT:ELMD) has a Due Diligence Score of 44, which is 18 points higher than the healthcare sector average of 26. It passed 15 out of 33 due diligence checks and has strong fundamentals. Electromed has seen its stock return 130.17% over the past year, overperforming other healthcare stocks by 225 percentage points.

Electromed has an average 1 year price target of $38.00, a downside of -17.94% from Electromed's current stock price of $46.31.

Electromed stock has a consensus Strong Buy recommendation according to Wall Street analysts. Of the 2 analysts covering Electromed, 100% have issued a Strong Buy rating, 0% have issued a Buy, 0% have issued a Hold, while 0% have issued a Sell rating, and 0% have issued a Strong Sell.

What are the healthcare stocks with highest dividends?

Out of 74 healthcare stocks that have issued dividends in the past year, the 3 healthcare stocks with the highest dividend yields are:

1. Dominari Holdings (NASDAQ:DOMH)

Dominari Holdings (NASDAQ:DOMH) has an annual dividend yield of 33.28%, which is 31 percentage points higher than the healthcare sector average of 2.65%.

Dominari Holdings's dividend payout ratio of -19.1% indicates that its high dividend yield might not be sustainable for the long-term.

2. Siga Technologies (NASDAQ:SIGA)

Siga Technologies (NASDAQ:SIGA) has an annual dividend yield of 16%, which is 13 percentage points higher than the healthcare sector average of 2.65%.

Siga Technologies's dividend payout ratio of 206.9% indicates that its high dividend yield might not be sustainable for the long-term.

3. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) has an annual dividend yield of 14.02%, which is 11 percentage points higher than the healthcare sector average of 2.65%.

Embecta's dividend payout ratio of 31.2% indicates that its high dividend yield is sustainable for the long-term.

Why are healthcare stocks down?

Healthcare stocks were down -0.32% in the last day, and up 2.16% over the last week. Adapthealth was the among the top losers in the healthcare sector, dropping -4.55% yesterday.

AdaptHealth shares are trading lower after Baird lowered its price target on the stock from $18 to $15.

What are the most undervalued healthcare stocks?

Based on the Valuation rating, one of the 7 components of a stocks overall Zen Ratings grade, which evaluates factors including estimated earnings yield, earnings before interest and taxes/enterprise value, cash flow yield, free cash flow to price, and price-to-earnings growth (PEG ratio), the 3 most undervalued healthcare stocks right now are:

1. Embecta (NASDAQ:EMBC)

Embecta (NASDAQ:EMBC) is the most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Embecta has a valuation score of 43, which is 30 points higher than the healthcare sector average of 13. It passed 3 out of 7 valuation due diligence checks.

Embecta's stock has dropped -67.3% in the past year. It has overperformed other stocks in the healthcare sector by 27 percentage points.

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

Ironwood Pharmaceuticals (NASDAQ:IRWD) is the second most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Ironwood Pharmaceuticals has a valuation score of 86, which is 73 points higher than the healthcare sector average of 13. It passed 6 out of 7 valuation due diligence checks.

Ironwood Pharmaceuticals's stock has gained 514.31% in the past year. It has overperformed other stocks in the healthcare sector by 609 percentage points.

3. Inmode (NASDAQ:INMD)

Inmode (NASDAQ:INMD) is the third most undervalued healthcare stock based on its Valuation Rating of A. Valuation is one of 7 Component Grades used to calculate the overall Zen Rating.

Inmode has a valuation score of 57, which is 44 points higher than the healthcare sector average of 13. It passed 4 out of 7 valuation due diligence checks.

Inmode's stock has dropped -3.31% in the past year. It has overperformed other stocks in the healthcare sector by 91 percentage points.

Are healthcare stocks a good buy now?

61.98% of healthcare stocks rated by analysts are a strong buy right now. On average, analysts expect healthcare stocks to rise by 27.99% over the next year.

5.22% of healthcare stocks have a Zen Rating of A (Strong Buy), 13.31% of healthcare stocks are rated B (Buy), 48.38% are rated C (Hold), 26% are rated D (Sell), and 7.09% are rated F (Strong Sell).

What is the average p/e ratio of the healthcare sector?

The average P/E ratio of the healthcare sector is 29.6x.

WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcareBest Healthcare Stocks to Buy Now (2026)Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.

Healthcare Industries

Healthcare Stocks FAQ

1. Bioventus (NASDAQ:BVS)

2. Immucell (NASDAQ:ICCC)

3. Electromed (NYSEMKT:ELMD)

1. Dominari Holdings (NASDAQ:DOMH)

2. Siga Technologies (NASDAQ:SIGA)

3. Embecta (NASDAQ:EMBC)

1. Embecta (NASDAQ:EMBC)

2. Ironwood Pharmaceuticals (NASDAQ:IRWD)

3. Inmode (NASDAQ:INMD)

Company

Stock Tools

Stock Ideas

Sectors & IndustriesHealthcare
Best Healthcare Stocks to Buy Now (2026)
Top healthcare stocks in 2026 ranked by overall Due Diligence Score. See the best healthcare stocks to buy now, according to analyst forecasts for the healthcare sector.